Back to top

BMRN Maintained by Oppenheimer -- Price Target Raised to $97.00

BMRN Maintained by Oppenheimer -- Price Target Raised to $97.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioMarin Pharmaceutical Inc. (BMRN)